Dr. Roland Van Kimmenade and I discuss: Liberal Fluid Intake Versus Fluid Restriction In Chronic Heart Failure March 30, 2025 Disclosures: TBD
Dr. Sergio Raposeiras Roubin and I Discuss: Dapagliflozin In Patients Undergoing Transcatheter Aortic Valve Implantantion March 29, 2025 Disclosures: TBD Copyright NEJM
Dr. Antonius Buescher and I discuss: Development And External Validation Of A Deep Learning Electrocardiogram Model For Risk Stratification Of Coronary Revascularization Need In The Emergency Department March 29, 2025 Disclosures: TBD
Dr. Luke Laffin and I discuss: Efficacy Of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension On A Standardized Antihypertensive Medication Regimen March 29, 2025 Disclosures: TBD
Dr. Hyo-Soo Kim and I discussed the HOST-BR trial on optimal DAPT duration and thrombosis-bleeding balance in ACS patients. 3-month DAPT reduced thrombosis vs. 1-month in high bleeding risk, and reduced bleeding vs. 12-month in low-risk patients March 29, 2025 Disclosures: TBD
Dr. Keyvan Karkouti and I discussed the FARES-II trial. PCC is superior to FP for hemostasis in managing excessive bleeding among cardiac surgery ptS with coagulopathy. March 29, 2025 Disclosures: TBD
Dr. Marc Bonaca and I discussed the STRIDE trial. Semaglutide improves functional outcomes in DM pts with symptomatic PAD, addressing a critical unmet need. March 29, 2025 Disclosures: TBD
Dr. Leslie Cho and Dr. C. Michael Gibson Review: Multiple analyses from the Clear Outcomes Study presented at ACC 2024 including those regarding Gender, Hispanic and Obesity s/b Esperion April 19, 2024 Disclosures: TBD
Dr. Moritz Seiffert and Dr. C. Michael Gibson Discuss: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients At Low To Intermediate Risk: One Year Outcomes Of The Randomized DEDICATE-DZHK6 Trial April 19, 2024 Disclosures: TBD
Dr. Jung-Min Ahn, Dr. Duk-Woo Park and Dr. C. Michael Gibson Discuss: Preventive PCI Or Medical Therapy Alone For Atherosclerotic Coronary Vulnerable Plaques April 8, 2024 Disclosures: TBD
